Activated Protein C Resistance and Factor V Leiden in Mexico
- 26 December 2007
- journal article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
- Vol. 14 (4), 428-437
- https://doi.org/10.1177/1076029607306807
Abstract
A common cause of hereditary thrombophilia is activated protein C resistance (APCR), and most cases result from factor V Leiden mutation. An APCR phenotype without association with factor V Leiden has been described. This transversal, observational, nonrandomized study evaluated these 2 phenomena in healthy indigenous and mestizo Mexican subjects (n = 4345), including 600 Mexican natives. No indigenous subjects had APCR, but 82 mestizo subjects did. After retesting, 50 subjects had a negative test. The remaining 32 subjects had factor V Leiden, giving a 0.85% prevalence of factor V Leiden in the mestizo Mexican population. Only 31% of APCR carriers had factor V Leiden. These results show a very low prevalence of APCR and factor V Leiden in Mexico. Except for factor V Leiden, there are no other mutations in the factor V gene responsible for the APCR phenotype. Acquired APCR is nearly twice as prevalent as the inherited variant.Keywords
This publication has 39 references indexed in Scilit:
- Thrombophilia in pregnancy: a systematic reviewBritish Journal of Haematology, 2005
- Venous Thrombosis Among Patients with AIDSClinical and Applied Thrombosis/hemostasis, 2004
- Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation aloneBritish Journal of Haematology, 2003
- Response to activated protein C decreases throughout pregnancyActa Obstetricia et Gynecologica Scandinavica, 2002
- Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosusBritish Journal of Haematology, 2002
- Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complicationsBlood Coagulation & Fibrinolysis, 2002
- Resistance to activated protein C in healthy women taking oral contraceptivesBritish Journal of Haematology, 1995
- Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.Journal of Medical Genetics, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Incidence and clinical characteristics of hereditary disorders associated with venous thrombosisAmerican Journal of Hematology, 1991